Address of Correspondent: Munich Re, 1000 Rue de la Gauchetière Ouest, 20e étage, Montréal Québec, H3B 4W5; 514-392-5069;
J Insur Med. 2023 Jul 1;50(2):147-149. doi: 10.17849/insm-50-2-147-149.1.
NAFLD (non-alcoholic fatty liver disease) and NASH (non-alcoholic steatohepatitis) are time-honored acronyms, with widely popular acceptance. Experts now recommend discarding them in favor of MASLD for "metabolic dysfunction-associated steatotic liver disease" and MASH for "metabolic dysfunction-associated steatohepatitis." The reasons for this change are explored and an argument about why the change is confusing, is advanced. Should these acronyms become clinically popular, risk assessment manuals will require updates.
NAFLD（非酒精性脂肪肝疾病）和 NASH（非酒精性脂肪性肝炎）是历史悠久的缩写词，被广泛接受。专家现在建议弃用这些缩写词，转而使用 MASLD 代表“代谢功能障碍相关脂肪性肝病”，以及 MASH 代表“代谢功能障碍相关脂肪性肝炎”。本文探讨了这种变化的原因，并提出了一个论点，即为什么这种变化令人困惑。如果这些缩写词在临床上变得流行，风险评估手册将需要更新。
